Operating Expenses Değişiklik Tarih
AbbVie USD 11.11B 540M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Astellas Pharma JPY 386.93B 57.73B 2023-09
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
Biogen USD 2.03B 344.1M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Takeda JPY 1.09T 202.38B 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12



Spectrum Pharmaceuticals Işletim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2024.